NLS Pharmaceutics AG (NLSPW)
0.01
-0.01 (-42.86%)
At close: Jan 15, 2025, 12:42 PM
0.01
0.00%
After-hours Jan 15, 2025, 12:42 PM EST
undefined% (undefined)
| Bid | 0.01 |
| Market Cap | 5.22M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.02 |
| Volume | 35,117 |
| Avg. Volume (20D) | 40,903 |
| Open | 0.02 |
| Previous Close | 0.02 |
| Day's Range | 0.01 - 0.02 |
| 52-Week Range | 0.01 - 0.10 |
| Beta | undefined |
About NLSPW
NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates includ...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 29, 2021
Employees NaN
Stock Exchange NASDAQ
Ticker Symbol NLSPW